|
A diagnosis of triple-negative breast cancer doesn't always mean cancer spread
April 14, 2008Triple-negative breast cancers are a heterogeneous group and may not always be associated with lymph node spread, a new study shows.
The study of 145 triple negative breast cancers (i.e, cancer which is estrogen receptor-negative, progesterone receptor-negative and HER2-negative) in 128 women found that about 23% were moderate or low-grade lesions, said Cecilia Mercado, MD, of New York University School of Medicine, and an author of the study.
Triple negative breast cancer is found in about 15% of breast cancer patients and the patients are usually younger.
The study found that 11 of the 145 cancers had a low histologic grade. Only one of these patients had evidence that their cancer had spread into their lymph nodes. Twenty-three cancers were moderate grade lesions; only five of these 23 had spread into the lymph nodes. That compares to 37 of 111 cancers with a high histologic grade which had lymph node metastases, Dr. Mercado said.
"Our preliminary results show that triple negative breast cancers are a heterogeneous group. Although many are high grade lesions, some are moderate or low grade demonstrating a lower rate of lymph node metastasis," Dr. Mercado said.
American Roentgen Ray Society
The study found that 11 of the 145 cancers had a low histologic grade. Only one of these patients had evidence that their cancer had spread into their lymph nodes. Twenty-three cancers were moderate grade lesions; only five of these 23 had spread into the lymph nodes. That compares to 37 of 111 cancers with a high histologic grade which had lymph node metastases, Dr. Mercado said.
"Our preliminary results show that triple negative breast cancers are a heterogeneous group. Although many are high grade lesions, some are moderate or low grade demonstrating a lower rate of lymph node metastasis," Dr. Mercado said.
American Roentgen Ray Society
Breast, Cancer News and Current Breast, Cancer Events RSSNew possibilities for breast cancer treatment on the horizon
he first patient scans from a custom-built scanner combining positron emission tomography (PET) and computed tomography (CT) technologies indicate that these scans could significantly improve breast cancer imaging capabilities and lead to more targeted treatment options, according to researchers at SNM's 55th Annual Meeting.
Previously unseen switch regulates breast cancer response to estrogen
A tiny modification called methylation on estrogen receptors prolongs the life of these growth-driving molecules in breast cancer cells, according to research by scientists at Emory University's Winship Cancer Institute.
Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.
Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.
Vitamin D and breast cancer risk
A connection between vitamin D level and the risk of developing breast cancer has been implicated for a long time, but its clinical relevance had not yet been proven.
Mammograms benefit women up to the age of 75 and 3-yearly screening intervals are best
Breast cancer screening is effective, appropriate and reduces deaths from the disease in women aged up to 75 years old according to new research in over 860,000 women aged 70-75 presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.
New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
Adding capecitabine, a drug that inhibits DNA synthesis and slows the growth of tumour tissue, to docetaxel, in patients with early breast cancer, leads to more toxicities and does not improve the efficacy of treatment.
Hereditary breast cancer -- a high cost to patient and health care provider alike
Some women who carry the BRCA gene mutation, which predisposes to breast cancer, may choose to have a prophylactic mastectomy rather than undertake lifetime surveillance, a Dutch scientist will tell the 6th European Breast Cancer Conference (EBCC-6) today (Wednesday 16 April).
Pregnant patients lose out in breast cancer treatment; a new approach is needed
Pregnant breast cancer patients can be treated as closely as possible to existing guidelines for non-pregnant patients, with few ill effects.
MRI before surgery leads to better-adapted treatment for breast cancer
The early use of magnetic resonance imaging (MRI) in women diagnosed with breast cancer can often lead to a better adapted surgical approach to the tumour.
More Breast, Cancer News Articles
 | Lopsided: How Having Breast Cancer Can Be Really Distracting by Meredith Norton |
 | Courageous Souls: Do We Plan Our Life Challenges Before Birth? by Robert Schwartz |
 | What Your Doctor May Not Tell You About Menopause (TM): The Breakthrough Book on Natural Hormone Balance by John R. Lee, Virginia Hopkins |
 | Dr. Susan Love's Breast Book:4th Edition 2005 by Susan Love |
 | The Middle Place (Voice) by Kelly Corrigan |
 | 7 Weeks to Safe Social Drinking: How to Effectively Moderate Your Alcohol Intake by Donna J. Cornett |
 | Pretty Is What Changes: Impossible Choices, The Breast Cancer Gene, and How I Defied My Destiny by Jessica Queller |
 | Just Get Me Through This!: The Practical Guide to Breast Cancer by Deborah A. Cohen, M.D., Robert M. Gelfand |
 | Refuge: An Unnatural History of Family and Place by Terry Tempest Williams |
 | Breast Cancer Husband : How to Help Your Wife (and Yourself) during Diagnosis, Treatment and Beyond by Marc Silver |
| © 2008 BrightSurf.com |